(Q43180981)

English

Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system

scientific article published in March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

0 references

endocannabinoid system

0 references

1 reference

based on heuristic

inferred from title

Sabrina Dallavalle

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

author name string

Sonia Gattinoni

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Chiara De Simone

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Filomena Fezza

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Raffaella Nannei

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Daniele Amadio

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Patrizia Minetti

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Gianandrea Quattrociocchi

8

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Antonio Caprioli

9

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Franco Borsini

10

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Sergio Penco

12

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Mauro Maccarrone

14

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

357-360

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

The palmitoylethanolamide family: a new class of anti-inflammatory agents?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

21 January 2018

Pharmacologic and Clinicopharmacologic Properties of SDZ ENA 713, a Centrally Selective Acetylcholinesterase Inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

21 January 2018

Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure and function of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the endocannabinoid system: to enhance or reduce?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Enzymatic pathways that regulate endocannabinoid signaling in the nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemical characterization of a family of brain lipids that induce sleep

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Enzymatic formation of anandamide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

An anorexic lipid mediator regulated by feeding.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

The endocannabinoid system in targeting inflammatory neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

The anandamide transport inhibitor AM404 activates vanilloid receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Anandamide transport inhibition by the vanilloid agonist olvanil

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Tandem mass spectrometric data-FAAH inhibitory activity relationships of some carbamic acid O-aryl esters

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovering potent and selective reversible inhibitors of enzymes in complex proteomes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Enantioselective RH-catalyzed hydrogenation of enol acetates and enol carbamates with monodentate phosphoramidites

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Covalent modifiers: an orthogonal approach to drug design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetylcholinesterase inhibition in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-like property concepts in pharmaceutical design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900472

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CMDC.200900472

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43180981&oldid=2188266931"